Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine
Clin. Gastroenterol. Hepatol. 2020 Aug 07;[EPub Ahead of Print], D Laharie, A Bourreille, J Branche, M Allez, Y Bouhnik, J Filippi, F Zerbib, G Savoye, L Vuitton, J Moreau, A Amiot, L Beaugerie, E Ricart, O Dewit, A Lopez-Sanroman, M Fumery, F Carbonnel, A Buisson, B Coffin, X Roblin, G van Assche, M Esteve, M Farkkila, JP Gisbert, P Marteau, S Nahon, M de Vos, L Peyrin-Biroulet, JY MaryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.